Valuation
- Market cap
- 1,026,081,000
- Revenue TTM
- $1,023,080,000
- Net income TTM
- $-47,100,000
- PE ratio
- 0.00
- Forward PE
- 42.32
- Profit margin
- -4.60%
- Debt to equity
- 1.36
Trading
- Volume
- 307,000
- Avg volume
- 415,212
- Day's range
- $10.65 – $10.98
- Shares out
- 96,075,000
- Stochastic %K
- 69%
- Beta
- —
- Analysts
- Strong Sell
- Price target
- $17.67
Company profile
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is ba...
Show more
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 919 763 1100
- Website
- https://www.lumexaimaging.com
- Address
- 4200 Six Forks Road, Suite 1000, Raleigh, United States
Latest news
No headlines yet.
